Literature DB >> 16950670

Activated c-Fms recruits Vav and Rac during CSF-1-induced cytoskeletal remodeling and spreading in osteoclasts.

Hiroaki Sakai1, Yan Chen, Takashi Itokawa, Kuan-Ping Yu, Mei-Ling Zhu, Karl Insogna.   

Abstract

Colony-stimulating factor-1 (CSF-1) induces osteoclast spreading that requires activation of c-Src and phosphatidyl inositol 3-kinase (PI3-K), both of which are recruited to activated c-Fms, the CSF-1 receptor. The present report provides evidence that the hemopoietic guanine nucleotide exchange factor (GEF), Vav, and its target GTPase, Rac, lie downstream from this initial signaling complex. CSF-1 treatment of osteoclast-like cells induced translocation of Vav to the plasma membrane, an increase in its phosphotyrosine content, and a concomitant decline in the amount of phosphoinositol 4,5-bisphosphate bound to Vav, changes known to induce Vav's GEF activity. CSF-1 induced the association of Vav and Rac and increased Rac's GTPase activity. CSF-1 also induced rapid translocation of Rac to the periphery of spreading neonatal rat osteoclasts where it co-localized primarily with Vav3 and to a lesser extent with Vav1. Wortmannin, an inhibitor of PI3-K, blocked CSF-1-induced Rac translocation and prevented CSF-1-induced spreading and actin reorganization in osteoclasts. CSF-1-induced osteoclast spreading was not significantly reduced in osteoclasts isolated from Vav1 knock-out mice and Vav1 knock-out mice had normal bone density. Microinjection of constitutively active Rac, but not constitutively active Cdc42 or RhoA, induced lamellipodia formation and osteoclast spreading, mimicking the effects of CSF-1. Dominant-negative Rac blocked CSF-1-induced osteoclast spreading, whereas neither dominant-negative Cdc42 nor C3, an inhibitor of RhoA, affected the response to CSF-1. These data demonstrate that Vav and Rac lie downstream from activated PI3-K in CSF-1-treated osteoclasts and that Rac is required for CSF-1-induced cytoskeletal remodeling in these cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16950670     DOI: 10.1016/j.bone.2006.06.012

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  21 in total

1.  Rac deletion in osteoclasts causes severe osteopetrosis.

Authors:  Monica Croke; F Patrick Ross; Matti Korhonen; David A Williams; Wei Zou; Steven L Teitelbaum
Journal:  J Cell Sci       Date:  2011-11-23       Impact factor: 5.285

2.  The Rac1 exchange factor Dock5 is essential for bone resorption by osteoclasts.

Authors:  Virginie Vives; Mélanie Laurin; Gaelle Cres; Pauline Larrousse; Zakia Morichaud; Danièle Noel; Jean-François Côté; Anne Blangy
Journal:  J Bone Miner Res       Date:  2011-05       Impact factor: 6.741

Review 3.  Regulation of tyrosine phosphorylation in macrophage phagocytosis and chemotaxis.

Authors:  Haein Park; Dan Ishihara; Dianne Cox
Journal:  Arch Biochem Biophys       Date:  2011-02-26       Impact factor: 4.013

Review 4.  Modulation of osteoclast differentiation and bone resorption by Rho GTPases.

Authors:  Heiani Touaitahuata; Anne Blangy; Virginie Vives
Journal:  Small GTPases       Date:  2014-03-10

5.  Intravital microscopy of osteolytic progression and therapy response of cancer lesions in the bone.

Authors:  Eleonora Dondossola; Stephanie Alexander; Boris M Holzapfel; Stefano Filippini; Michael W Starbuck; Robert M Hoffman; Nora Navone; Elena M De-Juan-Pardo; Christopher J Logothetis; Dietmar W Hutmacher; Peter Friedl
Journal:  Sci Transl Med       Date:  2018-08-01       Impact factor: 17.956

6.  The transcription factor T-box 3 regulates colony-stimulating factor 1-dependent Jun dimerization protein 2 expression and plays an important role in osteoclastogenesis.

Authors:  Chen Yao; Gang-Qing Yao; Ben-Hua Sun; Changqing Zhang; Steven M Tommasini; Karl Insogna
Journal:  J Biol Chem       Date:  2014-01-06       Impact factor: 5.157

7.  Osteoclasts lacking Rac2 have defective chemotaxis and resorptive activity.

Authors:  Takashi Itokowa; Mei-ling Zhu; Nancy Troiano; Jessica Bian; Tustomu Kawano; Karl Insogna
Journal:  Calcif Tissue Int       Date:  2010-11-26       Impact factor: 4.333

8.  Connective tissue growth factor in regulation of RhoA mediated cytoskeletal tension associated osteogenesis of mouse adipose-derived stromal cells.

Authors:  Yue Xu; Diane R Wagner; Elena Bekerman; Michael Chiou; Aaron W James; Dennis Carter; Michael T Longaker
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

9.  S100A4 regulates macrophage chemotaxis.

Authors:  Zhong-Hua Li; Natalya G Dulyaninova; Reniqua P House; Steven C Almo; Anne R Bresnick
Journal:  Mol Biol Cell       Date:  2010-06-02       Impact factor: 4.138

10.  Inhibition of Hsp90 activates osteoclast c-Src signaling and promotes growth of prostate carcinoma cells in bone.

Authors:  Akihiro Yano; Shinji Tsutsumi; Shiro Soga; Min-Jung Lee; Jane Trepel; Hiroyuki Osada; Len Neckers
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.